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Ligand-mediated dimerization has emerged as
a universal mechanism of growth factor receptor
activation. Neurotrophins interact with dimers of
the p75 neurotrophin receptor (p75NTR), but the
mechanism of receptor activation has remained
elusive. Here, we show that p75NTR forms disul-
phide-linked dimers independently of neurotrophin
binding through the highly conserved Cys257 in its
transmembrane domain. Mutation of Cys257 abol-
ished neurotrophin-dependent receptor activity but
did not affect downstream signaling by the p75NTR/
NgR/Lingo-1 complex in response to MAG, indi-
cating the existence of distinct, ligand-specific acti-
vation mechanisms for p75NTR. FRET experiments
revealed a close association of p75NTR intracellular
domains that was transiently disrupted by conforma-
tional changes induced upon NGF binding. Although
mutation of Cys257 did not alter the oligomeric state
of p75NTR, the mutant receptor was no longer able
to propagate conformational changes to the cyto-
plasmic domain upon ligand binding. We propose
that neurotrophins activate p75NTR by a mechanism
involving rearrangement of disulphide-linked
receptor subunits.
INTRODUCTION
The neurotrophins are a family of neurotrophic factors that
control multiple aspects of nervous system development and
function, including neurogenesis, neuronal differentiation, cell72 Neuron 62, 72–83, April 16, 2009 ª2009 Elsevier Inc.survival, neurite outgrowth, target innervation, and synaptic
plasticity (Bibel and Barde, 2000). Four neurotrophins are
present in mammals: nerve growth factor (NGF), brain-derived
neurotrophic factor (BDNF), neurotrophin-3 (NT-3), and neuro-
trophin-4 (NT-4). The neurotrophins are synthesized as a pre-
pro-peptide from which the mature portion is released by
proteolytic cleavage. The mature forms of neurotrophins
interact with two distinct receptors, a cognate member of the
Trk receptor tyrosine kinase family and the common p75 neuro-
trophin receptor (p75NTR), a member of the tumor necrosis
factor receptor (TNFR) superfamily of death receptors (Friedman
and Greene, 1999; Kaplan and Miller, 2000; Lee et al., 2001a;
Patapoutian and Reichardt, 2001). On the other hand, unpro-
cessed neurotrophins (proneurotrophins) are thought to display
selectivity for p75NTR over Trk receptors (Lee et al., 2001b) with
the aid of the coreceptor sortilin (Nykjaer et al., 2004). While this
interaction is thought to preferentially lead to cell death
(Lee et al., 2001b), cell survival is mediated by Trk signaling
(Patapoutian and Reichardt, 2001). A key issue in neurotrophin
research is the elucidation of the molecular mechanisms under-
lying each of the physiological actions of the neurotrophins in
different cell types, throughout development, and in patholog-
ical situations.
Unlike Trk receptors, p75NTR lacks catalytic activity. The intra-
cellular region of p75NTR contains a flexible juxtamembrane
segment followed by a globular domain known as the death
domain (Liepinsh et al., 1997). Signal transduction by p75NTR is
thought to proceed via ligand-dependent recruitment and
release of cytoplasmic effectors to and from the receptor. Over
20 different intracellular interactors of p75NTR have been identi-
fied to date (Barker, 2004; Bronfman and Fainzilber, 2004;
Dechant and Barde, 2002; Roux and Barker, 2002), but this
wealth of interactions has not translated in a comparable under-
standing of receptor function. Some of the major downstream
signaling events triggered by p75NTR in response to
Neuron
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c-jun kinase (JNK) (Friedman, 2000; Yoon et al., 1998), and cas-
pases (Troy et al., 2002). In addition, p75NTR can also activate the
small GTPase RhoA (Yamashita et al., 1999), but this requires
a different set of ligands derived from myelin, such as myelin-
associated glycoprotein (MAG) and Nogo (Wang et al., 2002;
Wong et al., 2002; Yamashita et al., 2002), and two different cor-
eceptors: a lipid-anchored ligand-binding subunit known as the
Nogo receptor (NgR) (Fournier et al., 2001) and Lingo-1 (Mi et al.,
2004). In addition, p75NTR is also known to undergo proteolytic
cleavage upon activation by several of its ligands or induction
of membrane metalloproteases with phorbol esters (Jung
et al., 2003; Kanning et al., 2003). The release of the p75NTR intra-
cellular domain following intramembrane cleavage by g-secre-
tase is thought to be required for activation of some signaling
pathways, such as NRIF-mediated neuronal death of sympa-
thetic neurons (Kenchappa et al., 2006).
Receptor oligomerization has been recognized as a crucial
step in the activation of many plasma membrane receptors. In
receptors carrying intrinsic kinase activity, ligand-mediated
dimerization stabilizes the active conformation of the kinase
domain by receptor trans-phosphorylation (Schlessinger,
2002). In noncatalytic receptors, such as cytokine and death
receptors, oligomerization of intracellular domains results in
recruitment of adaptors or activation of intracellularly bound
effectors (Ashkenazi and Dixit, 1999; Constantinescu et al.,
1999). However, while necessary, receptor oligomerization
may not always be sufficient for signaling. Several studies have
indicated that some cytokine and growth factor receptors exist
in a preassembled dimeric complex prior to ligand stimulation
and that receptor activation results from a ligand-mediated
change in the relative orientation of the two receptor protomers
(Jiang and Hunter, 1999; Seubert et al., 2003).
Although p75NTR was discovered over 20 years ago, and has
since been intensively studied, its mechanism of activation has
remained mysterious. Numerous studies have reported cross-
linking of radiolabeled neurotrophins to p75NTR dimers and
higher-order oligomers (Hempstead et al., 1991; Mahadeo
et al., 1994; Ryde´n et al., 1997), demonstrating the ability of
these ligands to directly bind oligomeric forms of this receptor.
Based on this evidence, and the dimeric nature of neurotrophins,
it has been assumed that these ligands activate p75NTR by clas-
sical ligand-mediated dimerization. A recent study has brought
support to this notion by solving the X-ray crystal structure of
a 2:2 complex between NT-3 and p75NTR (Gong et al., 2008).
In the same work, a 2:2 complex between NGF and p75NTR could
also be purified, and it was shown that the glycosylated extracel-
lular domain of p75NTR is monomeric in solution in the absence of
ligand, suggesting a general model of p75NTR dimerization by all
neurotrophins. In the present study, we investigated and charac-
terized endogenous determinants of receptor dimerization. We
discovered that full-length p75NTR forms disulphide-linked
dimers in the absence of neurotrophins through the highly
conserved Cys257 in its transmembrane domain. Functional
analysis of a p75NTR mutant lacking Cys257 revealed the func-
tional importance of disulphide-mediated receptor dimerization
and suggested a previously unknown mechanism of p75NTR
activation by neurotrophins.RESULTS
Transmembrane Cys257 Mediates Formation
of Disulphide-Linked p75NTR Dimers
Surface expression of p75NTR was assessed in transfected cells
following biotinylation of cell surface proteins, immunoprecipita-
tion, and gel electrophoresis under nonreducing and reducing
conditions. This analysis revealed that wild-type p75NTR forms
disulphide-linked dimers in the plasma membrane of transfected
cells (Figure 1A). At high levels of expression in COS-7 cells,
comparable amounts of cell surface p75NTR monomers and
disulphide-linked dimers could be detected under nonreducing
conditions (Figure 1A). However, the proportion of disulphide-
linked p75NTR dimers in transfected cells depended upon the
level of expression of the receptor. At moderate overexpression
levels, less than 10% of wild-type p75NTR was disulphide linked
(Figure 1B). NGF treatment had no effect on the proportion of
disulphide-linked p75NTR dimers (data not shown). Since neither
the extracellular (Gong et al., 2008; He and Garcia, 2004) nor
intracellular (Liepinsh et al., 1997) domains of p75NTR have
been reported to form disulphide-linked dimers, we turned our
attention to the transmembrane domain of the receptor, which
contains a Cys residue (Cys257) that is absolutely conserved in
all p75NTR orthologs known to date, from echinoderms to
mammals (Bothwell, 2006) (Figure 1C). Mutation of Cys257
to alanine (C257A) abolished the ability of p75NTR to form
disulphide-linked dimers (Figure 1A), indicating that such dimers
are generated by disulphide bonding of two p75NTR molecules
through Cys257 in the transmembrane domain. Disulphide-linked
dimers could also be detected to varying degrees on the surface
of cells endogenously expressing p75NTR, such as PC12 pheo-
chromocytoma, RN22 Schwannoma, and sympathetic neurons
from the rat superior cervical ganglion (SCG) (Figure 1D), as
well as in total extracts of newborn cortex, hippocampus, and
cerebellum (Figure 1E). Interestingly, in the latter cases the
majority of p75NTR was disulphide linked. Of note, a previous
study found high levels of disulphide-linked p75NTR dimers in
one melanoma cell line (A875) but not in another (HS294) (Grob
et al., 1985). Importantly, the C257A mutation did not affect the
ability of p75NTR to bind NGF (Figure 1F), nor its capacity to
undergo g-secretase-dependent intramembrane cleavage
upon stimulation with the phorbol ester PMA (Figure 1G).
Cys257 Is Essential for p75NTR Signaling in Response
to Neurotrophins
The ability of native p75NTR to form disulphide-linked dimers
prompted the question of its possible significance to p75NTR
activation and downstream signaling. We therefore investigated
the effects of the C257A mutation on the ability of the receptor to
recruit intracellular effectors and activate downstream pathways
in response to NGF. Unlike wild-type p75NTR, the C257A mutant
was unable to interact with NRIF, either in the presence or
absence of NGF (Figure 2A). Although a weak interaction could
be observed between the C257A mutant and TRAF6, this was
not increased by NGF treatment, which on the other hand readily
promoted TRAF6 recruitment to wild-type receptors (Figure 2B).
These data suggested that, although wild-type p75NTR is present
as both monomers and disulphide-linked dimers at the cellNeuron 62, 72–83, April 16, 2009 ª2009 Elsevier Inc. 73
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Activation Mechanism of the p75NTRFigure 1. Transmembrane Cys257 Mediates Formation of Disulphide-Linked p75NTR Dimers
(A) Cell surface expression of disulphide-linked p75NTR dimers (dim) and monomers (mon) in transfected COS-7 cells visualized by neutravidin probing of p75NTR
immunoprecipitates under nonreducing (–DTT) and reducing (+DTT) conditions. In nonreducing conditions, p75NTR dimers run somewhat higher, and monomers
lower, than their predicted molecular weights.
(B) Cell surface expression of disulphide-linked p75NTR dimers (dim) and monomers (mon) in COS-7 cells transfected with different amounts of wild-type p75NTR.
Immunoprecipitates were electrophoresed under nonreducing conditions, and p75NTR was visualized by neutravidin probing of p75NTR immunoprecipitates.
Results are expressed as mean dimer/monomer ratio.
(C) Alignment of p75NTR transmembrane domain sequences from vertebrate and invertebrate species.
(D) Cell surface expression of endogenous disulphide-linked p75NTR dimers (dim) and monomers (mon) in PC12 cells, RN22 Schwannoma cells, and SCG sympa-
thetic neurons visualized by neutravidin probing of p75NTR immunoprecipitates. Control, untransfected COS cells.
(E) Expression of endogenous disulphide-linked p75NTR dimers (dim) and monomers (mon) in extracts of newborn rat cerebellum (cblm), cortex (ctx), and hippo-
campus (hc) visualized by immunoblotting of p75NTR immunoprecipitates under reducing and nonreducing conditions. The control lane represents a mock immu-
noprecipitate of the cblm extract.
(F) Binding of 125I-NGF to wild-type and C257A p75NTR analyzed by chemical crosslinking. Samples were run under reducing conditions. For each construct,
binding counts were normalized to levels of expression as assessed by immunoblotting (IB). Results are expressed as mean ± SD of three independent deter-
minations.
(G) g-secretase-dependent intramembrane cleavage of C257A p75NTR following stimulation with PMA in transfected COS cells. The proteasome inhibitor epox-
omycin was used to prevent degradation of CTF and ICD fragments. Mutant and wild-type (WT) p75NTR molecules were visualized by immunoblotting. The
g-secretase inhibitor DAPT blocked the generation of p75NTR intracellular domain (ICD). CTF, carboxy terminal fragment.membrane, only the latter appear to be capable of recruiting
downstream effectors such as NRIF and TRAF6 in a ligand-
dependent manner. In order to address this directly, we tested
the ability of NRIF and TRAF6 to differentially interact with mono-
mers and disulphide-linked dimers of wild-type p75NTR by
analyzing pull-down products under reducing and nonreducing
conditions. We found that NRIF interacted exclusively with disul-
phide-linked p75NTR dimers, but not at all with monomers, and
NGF treatment could readily increase this interaction
(Figure 2C). On the other hand, although TRAF6 could pull
down both p75NTR monomers and dimers, NGF treatment only
stimulated TRAF6 binding to p75NTR dimers, but not monomers
(Figure 2D). Also in sympathetic neurons from rat SCG, NRIF
interacted only with p75NTR disulphide-linked dimers, not with74 Neuron 62, 72–83, April 16, 2009 ª2009 Elsevier Inc.monomers, and BDNF treatment strongly stimulated NRIF
recruitment to the receptor (Figure 2E).
We also examined three different downstream readouts of
p75NTR activity in transfected fibroblasts and 293 cells, including
activation of NF-kB (Figure 3A), caspase-3 (Figure 3B), and
induction of cell death (Figure 3C) in response to NGF. In all
cases, the C257A mutant was unresponsive to stimulation, indi-
cating that Cys257 is required for neurotrophin-dependent
p75NTR signaling and downstream biological effects.
In order to probe the functional importance of Cys257 for
p75NTR signaling in a more physiological context, we developed
two shRNA constructs directed to 30 UTR sequences of the rat
p75NTR mRNA to knock down endogenous p75NTR expression
in neurons. When introduced together into primary cultures of
Neuron
Activation Mechanism of the p75NTRFigure 2. Cys257 Is Essential for Recruitment of NRIF and TRAF6 to p75NTR in Response to NGF
(A) Binding of NRIF to wild-type and mutant p75NTR in transfected HEK293 cells assayed by immunoprecipitation (IP) and immunoblotting (IB).
(B) Binding of TRAF6 to wild-type and mutant p75NTR in transfected HEK293 cells.
(C) Binding of NRIF to wild-type and mutant p75NTR in transfected HEK293 cells. Prior to gel electrophoresis, the pull-down sample was split into two equal parts:
one was boiled in sample buffer, and the other was treated with 1 M DTT prior to boiling. The migration of p75NTR dimers and monomers is indicated.
(D) Binding of TRAF6 to wild-type and mutant p75NTR in transfected HEK293 cells analyzed as in panel (C).
(E) Binding of NRIF to wild-type and mutant p75NTR in rat SCG neurons. NRIF only interacts with p75NTR disulphide-linked dimers, not monomers.rat SCG neurons, these shRNAs effectively suppressed endog-
enous p75NTR expression, while a control shRNA had no effect
(Figure 4A). As expected, control shRNA did not affect the ability
of BDNF to induce JNK phosphorylation (Figure 4B) and cell
death (Figure 4C) in SCG neurons, which express p75NTR and
TrkA but not TrkB. In contrast, shRNAs directed against
p75NTR abolished both responses, indicating their dependence
on p75NTR signaling (Figures 4B and 4C). Under those condi-
tions, BDNF-mediated JNK phosphorylation and cell death
could be restored by introduction of a wild-type p75NTR expres-
sion construct that is insensitive to our p75NTR shRNAs (Figures
4B and 4C). In contrast to the wild-type construct, the C257A
mutant was unable to restore either JNK phosphorylation or
cell death in response to BDNF in SCG neurons (Figures 4B
and 4C). Together, these results demonstrate that Cys257 is
essential for p75NTR signaling in response to neurotrophins and
support the notion that disulphide-linked p75NTR dimers are
the active, neurotrophin-sensitive receptor species in neurons.Cys257 Is Not Required for Downstream Signaling by the
p75NTR/NgR/Lingo-1 Complex in Response to MAG
The importance of Cys257 in neurotrophin-dependent p75NTR
signaling prompted the question of its role in the activation of
p75NTR by other types of ligands. We therefore tested the ability
of wild-type and mutant p75NTR to recruit RhoGDI and to
increase RhoA activity in response to the myelin-derived ligand
MAG. These activities require the presence of two additional
receptor subunits, NgR and Lingo-1. Interestingly, cells ex-
pressing p75NTR, NgR, and Lingo-1 responded equally well to
stimulation with MAG in both RhoGDI recruitment to p75NTR
(Figure 5A) and RhoA activity (Figure 5B), regardless of whether
they received wild-type or the C257A mutant. Thus, and in
contrast to activation by neurotrophins, Cys257 is not required
for the ability of p75NTR to signal in response to the non-
neurotrophin ligand MAG, suggesting the existence of mecha-
nistic differences in the activation of p75NTR by different
ligands.Neuron 62, 72–83, April 16, 2009 ª2009 Elsevier Inc. 75
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Activation Mechanism of the p75NTRFigure 3. Cys257 Is Essential for p75NTR Signaling to NF-kB, Caspase-3, and Cell Death in Response to NGF
(A) NF-kB activity in transfected M23 fibroblasts in the presence and absence of NGF.
(B) Activation of caspase-3 visualized with a cleavage-specific antibody in HEK293 cells transfected with p75NTR constructs in response to NGF. Reprobing
controls for p75NTR and GAPDH are shown.
(C) Cell death assay in HEK293 cells transfected with p75NTR constructs in response to NGF. Results are expressed as mean ± SD of three independent exper-
iments, each performed in duplicate.Cys257 Allows Disulphide-Linked p75NTR Dimers
to Propagate Conformational Changes to Intracellular
Domains following NGF Binding
How does Cys257 contribute to p75NTR signaling in response to
neurotrophins? Its localization in the transmembrane domain
suggested that it may play a role in the mechanism of receptor
activation, either by regulating p75NTR oligomerization or by
allowing the propagation of conformational changes induced
by neurotrophin binding. Although Cys257 clearly contributes to
the formation of disulphide-linked p75NTR dimers, it remained
unclear whether this was the primary determinant of receptor76 Neuron 62, 72–83, April 16, 2009 ª2009 Elsevier Inc.oligomerization. In particular, the ability of the C257A mutant to
bind NGF at normal levels (Figure 1E) suggested that the muta-
tion may not have disrupted the oligomeric state of p75NTR at
the cell surface, as this would have been expected to affect
ligand binding affinity. In order to examine the possible role of
noncovalent interactions in p75NTR oligomerization, we per-
formed chemical crosslinking studies of wild-type and mutant
cell surface receptors in living COS-7 cells. Following chemical
crosslinking of cell surface proteins, p75NTR was immunoprecip-
itated from cell lysates and then subjected to SDS/PAGE under
reducing conditions, so that only oligomeric complexesFigure 4. Cys257 Is Essential for p75NTR Signaling in SCG Neurons
(A) Downregulation of p75NTR expression in rat SCG neurons following transfection of p75NTR shRNAs.
(B) Assay of JNK phosphorylation in SCG neurons in response to BDNF. SCG neurons were transfected with the indicated shRNA constructs. In rescue exper-
iments, wild-type p75NTR or C257A p75NTR constructs insensitive to p75NTR shRNAs were also introduced by DNA transfection. JNK phosphorylation was
assessed by immunoblotting of total cell lysates.
(C) Cell death in SCG neurons transfected with p75NTR shRNAs in response to BDNF. Rescue experiments with wild-type and C257A p75NTR constructs were
performed as above. *p < 0.05 versus wild-type, n = 3.
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Activation Mechanism of the p75NTRFigure 5. Cys257 Is Not Required for Downstream Signaling by the
p75NTR/NgR/Lingo-1 Complex in Response to MAG
(A) Binding of RhoGDI to wild-type and C257A p75NTR in COS-7 cells cotrans-
fected with NgR and Lingo-1 and stimulated with MAG-Fc.
(B) RhoA activity in COS-7 cells transfected with wild-type and mutant p75NTR
in the presence of NgR and Lingo-1 after stimulation with MAG-Fc for 30 min.
Results are expressed as mean ± SD relative to wild-type without MAG treat-
ment. *p < 0.05 versus control, n = 3.stabilized by chemical crosslinking would be visualized. As
expected, chemical crosslinking allowed the detection of wild-
type receptor dimers (Figure 6A), demonstrating that p75NTR
indeed forms dimers at the surface of living cells in the absence
of ligand. As chemical crosslinkers have only a limited efficiency,
the actual proportion of receptor dimers and monomers at the
cell surface cannot be determined with this method. NGF binding
did not alter the proportion of p75NTR dimers detected by chem-
ical crosslinking in transfected cells (Figure 6A). Surprisingly,
however, mutation of Cys257 did not affect the proportion of
p75NTR dimers detected after chemical crosslinking, either in
the absence or presence of NGF (Figure 6A). This indicated
that p75NTR may still oligomerize in the absence of Cys257
through noncovalent interactions.
Inspection of the p75NTR transmembrane domain revealed
the presence of a relatively well conserved AxxxG266 motif(Figure 6B), which is characteristic of self-associating transmem-
brane domains, including those from integrins and glycophorin A
(GpA) (Kubatzky et al., 2001). Interactions between isolated
transmembrane domains can be studied in a biological
membrane using the bacterial ToxCAT system (Russ and Engel-
man, 1999) (see Experimental Procedures for further details).
Dimerization of wild-type and mutant p75NTR transmembrane
domains was assessed along with wild-type GpA transmem-
brane domain, which is known for its strong self-association,
and a GpA point mutant (G83I) that disrupts homodimerization,
as positive and negative controls, respectively. The transmem-
brane domain of p75NTR was found to homodimerize in this
system to about 60% of the level shown by GpA (Figure 6C).
Mutation of Cys257 had only a small effect on transmembrane ho-
modimerization (Figure 6C). In contrast, mutation of Gly266 to Ile
(G266I), which is analogous to the G83I in GpA, abolished self-
association of the p75NTR transmembrane domain (Figure 6C).
When introduced in full-length p75NTR together with C257A,
the G266I mutation diminished the formation of p75NTR dimers
at the plasma membrane (Figure 6D). Together, these data indi-
cate that p75NTR homodimers can be stabilized at the cell
surface by both covalent and noncovalent interactions between
transmembrane domains and that the primary function of Cys257
is not in the formation of receptor dimers.
We then considered the possibility that Cys257 may instead
contribute to p75NTR signaling by mediating the propagation of
conformational changes induced by neurotrophin binding. We
reasoned that conformational changes involving alterations in
the relative positions of p75NTR intracellular domains may be de-
tected by fluorescence resonance energy transfer (FRET). Unlike
methods based on enzyme complementation, in FRET, the
transfer of energy between two chromophores depends both
on the distance between them and their relative orientation,
and it is therefore more suitable to quantitatively assess confor-
mational rearrangements of receptor subunits in a complex. We
chose homo-FRET over other more conventional FRET tech-
niques because of its greater sensitivity and the advantage of
using a single spectral variant to detect interactions between
identical molecules (Squire et al., 2004). Homo-FRET can be de-
tected as a decrease in steady-state fluorescence anisotropy
that results from energy transfer between identical fluorophores.
Monomeric enhanced green fluorescent protein (EGFP1)
displays high anisotropy (i.e., low FRET), while a concatenated
EGFP trimer (EGFP3) shows very low anisotropy (i.e., very high
FRET), and they were used as negative and positive controls,
respectively (Figures 7A, 7B, and 7E). Wild-type and C257A
p75NTR were tagged at the C terminus with monomeric EGFP
(see Experimental Procedures) and transfected in COS-7 cells.
Anisotropy and total fluorescence were measured at different
locations in the plasma membrane of transfected cells. At basal
conditions, wild-type p75NTR-EGFP displayed lower anisotropy
than EGFP1 (i.e., higher FRET) at the plasma membrane (Figures
7C and 7E), in agreement with its oligomeric state in living cells.
Using the anisotropy value of EGFP1 as baseline, the FRET level
of wild-type p75NTR-EGFP could be estimated to be about 25%
that of EGFP3 (Figure 7E), which gives a very strong FRET signal.
Mutant C257A p75NTR-EGFP also showed lower anisotropy than
EGFP1 at the cell surface, albeit not as much as wild-typeNeuron 62, 72–83, April 16, 2009 ª2009 Elsevier Inc. 77
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crosslinking studies showing that this mutant retains the ability
to form dimers at the plasma membrane. Interestingly, both
p75NTR-EGFP constructs appeared mainly monomeric at intra-
cellular locations (Figures 7C and 7D), suggesting that oligomer-
ization occurs upon transit to the plasma membrane.
NGF was added to cells expressing wild-type and C257A
p75NTR-EGFP, and changes in anisotropy were evaluated by
time-lapse microscopy. Acute addition of NGF produced an
increase in anisotropy (i.e., decrease in FRET) at the plasma
membrane of cells expressing wild-type p75NTR-EGFP
(Figure 7E). This anisotropy rise was observed in all cells exam-
ined (n = 30), showed a consistent peak 2–3 min after NGF addi-
tion, and lasted for 3–10 min, waning toward the end of the
recording (15 min) (Figures 7F and 7G). In contrast, NGF had
no effect on cell surface anisotropy in cells expressing the
mutant C257A p75NTR-EGFP (n = 22 cells examined) (Figures
7F and 7G). These results indicate that NGF induces a decrease
in FRET in wild-type p75NTR-EGFP at the plasma membrane,
indicating that receptor activation by neurotrophins involves
conformational changes in the relative position or orientation of
p75NTR intracellular domains. The inability of NGF to induce
any change in FRET in cells expressing C257A p75NTR-EGFP
correlates with the loss of neurotrophin-dependent p75NTR
signaling in this mutant and supports a role for Cys257 in the
propagation of conformational changes induced by neurotrophin
binding.
Figure 6. Cell Surface p75NTR Dimerization
Is Mediated by Covalent and Noncovalent
Interactions between Transmembrane
Domains
(A) Wild-type and C257A p75NTR dimers analyzed
by cell surface chemical crosslinking under
reducing conditions. Cell lysates were immuno-
precipitated with anti-p75NTR antibodies; immuno-
blot was probed with anti-HA antibodies.
(B) Alignment of p75NTR transmembrane domains
highlighting the AxxxG self-association motif and
Gly266.
(C) ToxCAT assay of self-association of wild-type
and mutant p75NTR transmembrane domains.
Wild-type and mutant transmembrane domains
from glycophorin A (GpATM) were used as positive
and negative controls, respectively.
(D) Wild-type and mutant p75NTR dimers analyzed
by cell surface chemical crosslinking as above.
DISCUSSION
In this study, we have investigated the
mechanism of activation of the p75 neu-
rotrophin receptor. The first major finding
of this work is the ability of native p75NTR
to form disulphide-linked dimers through
the conserved Cys257 in the transmem-
brane domain. The second is the unex-
pected requirement of this cysteine
residue for the recruitment of intracellular
effectors and downstream signaling by p75NTR in response to
neurotrophins, but not in response to other ligands, such as
MAG. The third is the ability of the p75NTR dimer to undergo
a conformational change in response to NGF and the essential
role of Cys257 in this process. Based on these observations,
we propose a previously unknown mechanism of receptor
activation involving ligand-induced rearrangement of disul-
phide-linked receptor subunits.
While it is relatively straightforward to visualize how receptor
kinases may become activated upon ligand binding (Schles-
singer, 2002), this is less obvious for noncatalytic receptors.
Since these signal by selective interactions with intracellular
effectors, the question that arises is how ligand binding regulates
those interactions. Clearly, something ought to change in the
receptor after ligand binding that makes its intracellular domain
more or less prone to interact with downstream effectors. Ligand
binding may change the oligomerization state of the receptor—
by, for example, inducing dimers—leading to cooperative
binding or release of downstream effectors. Although this has
been the prevalent model for p75NTR activation to date, our
results show that the active p75NTR species pre-exists as a disul-
phide-linked dimer, which is essential for downstream signaling
in response to neurotrophins, obviating a classical ligand-medi-
ated dimerization mechanism. Although an earlier study using
artificially deglycosylated p75NTR extracellular domain had sug-
gested that NGF may activate a preformed receptor dimer by
inducing its dissociation into monomers (He and Garcia, 2004),78 Neuron 62, 72–83, April 16, 2009 ª2009 Elsevier Inc.
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Activation Mechanism of the p75NTRFigure 7. Analysis of Conformational Changes in p75NTR Intracellular Domains by Anisotropy Microscopy
(A–D) Steady-state anisotropy in transfected cells. Examples of areas used for anisotropy measurements are boxed and shown as high-magnification insets.
Monomeric EGFP (EGFP1, high anisotropy, low FRET) and a concatenated EGFP trimer (EGFP3, low anisotropy, high FRET) were used as controls. The calibra-
tion bar of the look-up table is shown below.
(E) Steady-state anisotropy of wild-type and C257A p75NTR-EGFP in COS-7 cells. The anisotropy value of EGFP1 was arbitrarily set to zero and used as baseline
for the histogram. Bars show average ± SD (n = 8–11 cells for EGFP and 22–30 cells for p75NTR).
(F) Representative examples of anisotropy traces after addition of NGF or medium in cells expressing wild-type or C257A p75NTR-EGFP. A peak in anisotropy was
observed after NGF addition in all cells expressing wild-type p75NTR that were examined (n = 30) regardless of their initial baseline anisotropy level.
(G) Anisotropy change after addition of NGF or medium. The difference in anisotropy before and after addition of NGF (i.e., peak minus baseline value) or medium
was calculated for wild-type and C257A p75NTR-EGFP. Results are expressed as average ± SD (n = 15–17 cells examined). *p < 0.0001 versus C257A.more recent work has clearly shown that glycosylated p75NTR
extracellular domain is monomeric in the absence of ligand and
that NGF interacts with p75NTR dimers, not monomers (Gong
et al., 2008). Another possible mechanism for receptor activation
is that ligand binding changes the relative orientation of receptor
subunits in a dimeric or multimeric receptor complex. In some
cytokine and growth factor receptors, this is achieved through
the relative rotation of their transmembrane domains within the
plane of the membrane (Moriki et al., 2001; Seubert et al.,
2003). In the case of p75NTR, however, the disulphide link formed
by Cys257 in the transmembrane domain clearly restricts the
possibilities for relative movement of receptor subunits.
Our FRET experiments indicate that the two intracellular
domains of the p75NTR dimer are in close proximity under basal
conditions. This is in agreement with data from a recent study
using a b-gal complementation strategy (Wehrman et al.,
2007). Unlike FRET, however, enzyme complementation gives
an all-or-none response at the single-molecule level and is hence
less suited to reveal subtle conformational changes that do not
alter the oligomeric state of the receptor. In our experiments,
we observed a consistent decrease in FRET upon NGF bindingto wild-type p75NTR. This could either result from a separation
of p75NTR intracellular domains or changes in their relative orien-
tation due to rotation of receptor subunits. Although these two
possibilities are not mutually exclusive, it is difficult to envision
how changes in the relative orientation of intracellular domains
can be brought about by ligand binding to the extracellular region
of a dimeric receptor that is covalently crosslinked at the plasma
membrane. As explained above, a disulphide bridge linking the
transmembrane regions of two receptor subunits would clearly
prevent the propagation of rotational movements from the extra-
cellular to the intracellular domains. Thus, we believe that the
decrease in FRET observed after NGF binding most likely
reflects the separation of p75NTR intracellular domains. Impor-
tantly, and in contrast to the wild-type receptor, we found no
evidence of NGF-mediated conformational changes in the intra-
cellular domain of the C257A p75NTR mutant. Based on these
observations, we propose that neurotrophin binding produces
a scissors-like movement of disulphide-linked p75NTR subunits
with the Cys257-Cys257 disulphide link acting as the fulcrum,
thereby altering the relative proximity of intracellular domains
(Figure 8). In this model, Cys257 would function as the pin in theNeuron 62, 72–83, April 16, 2009 ª2009 Elsevier Inc. 79
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Activation Mechanism of the p75NTRFigure 8. The ‘‘Snail-Tong’’ Mechanism of p75NTR Activation in Response to Neurotrophins
Hypothetical schematic of p75NTR in the cell membrane before and after neurotrophin binding (based on structures determined by Gong et al. [2008] and Liepinsh
et al. [1997]). The approximate position of Cys257 is indicated. Arrows denote the postulated ‘‘snail-tong’’ movement of p75NTR subunits initiated by ligand binding:
closing onto the neurotrophin dimer in the outside, opening in the inside.scissors: in its absence, relative movements at one end cannot
be propagated to the other. Unlike normal scissors, however,
our results suggest that as the extracellular domains come closer
together on binding to the neurotrophin dimer, the intracellular
domains separate, not unlike a ‘‘snail-tong’’ mechanism
(Figure 8). This type of movement could be achieved if the
p75NTR protein were to be kinked, as opposed to straight, rela-
tive to the plane of the plasma membrane, in the vicinity of
Cys257. Proline residues are known to introduce kinks that may
vary from 5 to 50 and are common in transmembrane helices
(Yohannan et al., 2004). Thus, the highly conserved Pro254, three
residues upstream of Cys257 (see Figure 1C), seems like a good
candidate for such function. Although not as well conserved, an
unusual Pro triad is also present in the intracellular juxtamem-
brane region of p75NTR, 20 residues away from the plasma
membrane (Pro295-Pro296-Pro297). This portion of p75NTR is not
known to be helical in vivo and has been characterized by
nuclear magnetic resonance as unstructured in solution
(Liepinsh et al., 1997). The conformational changes inferred
from our FRET experiments require a relatively rigid structure
connecting the extra- and intracellular domains and suggest
that the juxtamembrane region of p75NTR may be stabilized
in vivo by interaction with other intracellular components.
The conformational changes observed upon NGF binding
showed a characteristic maximum at 2–3 min after NGF addition80 Neuron 62, 72–83, April 16, 2009 ª2009 Elsevier Inc.and lasted for an additional 3–10 min. This kinetics is consistent
with the onset of p75NTR internalization and downstream
signaling, which requires at least 15 min after ligand stimulation
(Bronfman et al., 2003). The separation of intracellular domains
induced by NGF binding may facilitate the recruitment of down-
stream effectors by exposing determinants important for their
interaction with the receptor. This may be particularly important
for receptors with relatively small intracellular domains, such as
p75NTR. Weak homotypic interactions between these domains
may keep the receptor in a closed, inactive state and could
potentially explain the residual amount of dimers observed after
simultaneous mutation of Cys257 and Gly266. Although the
p75NTR death domain was found to be monomeric in solution
up to 2.5 mM (Liepinsh et al., 1997), such interactions might be
detected in crystallization experiments. Even though it is unclear
at present why the conformational change observed is not sus-
tained for longer periods of time, the variation observed in its
duration could reflect interactions with different effector mole-
cules or activation of different downstream signaling events.
That p75NTR activation involves separation of intracellular
domains is consistent with a previous study using chimeric intra-
cellular domains artificially tethered to the plasma membrane
that were induced to dimerize by addition of a dimeric drug
(Wang et al., 2000). In this work, dimerization inhibited the proa-
poptotic effect of the constructs, from which the authors inferred
Neuron
Activation Mechanism of the p75NTRthat neurotrophin-mediated receptor dimerization should like-
wise silence p75NTR activity, a conclusion that was at odds
with the bulk of studies in the field. Our results indicating that
p75NTR is already dimeric before ligand binding and that
p75NTR activation by NGF involves the separation of intracellular
domains reconcile those results and suggest that this is in fact
the way in which neurotrophins activate this receptor.
Previous work has shown that p75NTR can enhance Trk
responses to neurotrophins, particularly when these are present
at limiting concentrations. For example, sensory and sympathetic
neurons from p75NTR knockout mice show reduced responsive-
ness to NGF (Lee et al., 1994), and a mutant NGF unable to
bind p75NTR displays lower binding affinity and reduced biological
activity in PC12 cells and sensory and sympathetic neurons
(Ryde´n et al., 1997). This positive modulatory role of p75NTR on
neurotrophin activities mediated by Trk receptors has been attrib-
uted to receptor-receptor interactions and/or ligand concentra-
tion or presentation effects. It is unclear at present whether these
activities require disulphide-linked dimerization of p75NTR. Given
the proposed role for the TrkA and p75NTR transmembrane
domains in their functional interaction (Esposito et al., 2001), it
is possible that formation of high-affinity NGF-binding sites may
be sensitive to conformational changes mediated by Cys257.
The fact that p75NTR signaling in response to MAG does not
require Cys257 suggests that myelin-derived ligands activate
p75NTR by a different mechanism. Although our results indicate
that disulphide-linked dimerization is important for p75NTR acti-
vation by neurotrophins, the stoichiometry of the complex
formed by p75NTR, NgR, and Lingo-1 needs to be further inves-
tigated. The lack of involvement of Cys257 in signaling by MAG
opens an opportunity to specifically disrupt neurotrophin-
specific p75NTR effects in loss-of-function studies. Intriguingly,
we found that the proportion of cell surface disulphide-linked
p75NTR dimers varied in different cell types and with different
levels of receptor expression. As only such dimers are able to
respond to neurotrophins, changes in their proportion or abun-
dance at the cell surface, e.g., between different cell types or
in response to external stimuli or redox states, could determine
the relative degree of p75NTR responsiveness to different ligands.
Cys257 represents a critical element in the activation mecha-
nism of p75NTR by neurotrophins and is absolutely conserved
in all vertebrate and invertebrate p75NTR molecules isolated so
far (Bothwell, 2006). We propose that neurotrophins neither acti-
vate p75NTR by inducing receptor dimers or disassembly into
monomers, as previously suggested, but through a rearrange-
ment of disulphide-linked receptor subunits. Many receptors in
the TNFR superfamily—to which p75NTR belongs—bear intra-
membrane cysteines, including Fas, DR6, RANK, RELT, BCM,
TACI, CD30, CD40, and receptors for TNF, lymphotoxin beta,
and TRAIL. The ‘‘snail-tong’’ mechanism described here could
therefore represent a general way by which receptors bearing in-
tramembrane cysteines are activated.
EXPERIMENTAL PROCEDURES
Plasmids, Antibodies, Proteins, and Chemicals
Rat p75NTR was expressed from the pCDNA3 vector backbone (Invitrogen)
using a full-length coding sequence flanked by an N-terminal hemagglutinin(HA) epitope tag. Mutations were introduced using QuickChange (Stratagene)
and verified by DNA sequencing. Plasmids to express RIP2, TRAF6, NRIF, sor-
tilin, Lingo-1, and RhoGDI were previously described. EGFP plasmid was from
Clontech. Luciferase reporter plasmid for NF-kB was from Promega. The origin
of antibodies were as follows: MC192 anti-p75NTR from Phil Barker; anti-HA
from Roche; anti-myc, anti-phospho, and -total JNK, cleavage-specific anti-
caspase-3, anti-RhoA, and anti-RhoGDI from Cell Signaling; anti-tubulin
from Sigma. NGF was purchased from Alomone Labs; MAG-Fc from R&D.
NGF was typically applied at 100 ng/ml for 30 min unless otherwise indicated.
MAG-Fc was used at 25 mg/ml for 30 min. PMA was used at 200 nM for 1 hr.
Epoxomycin (1 mM) and DAPT (2 mM) were applied 1.5 hr prior to PMA. All
compounds were from Sigma.
Cell Transfection and Tissue Culture
COS-7 cells were transfected with polyethylenimine (PEI). HEK293 and M23
cells were transfected with Lipofectamine 2000 (GIBCO). M23 is a clonal deriv-
ative of MG87 cells (Eketja¨ll et al., 1999), originally derived from mouse NIH 3T3
fibroblasts. Cells were typically used on the second day after transfection for
short-term signaling assays, at which point cell death was still low or undetect-
able. We found that different signaling assays worked best in different cell
lines: RhoA and RhoGDI in COS-7, NF-kB in M23 and P-JNK, and caspase-3
in HEK293 cells. This may be related to the specific complement of down-
stream effectors expressed by each cell type. Cell lines were cultured under
standard conditions and primary neurons in serum-free, N2-supplemented
DMEM:F12 medium (GIBCO).
Sympathetic Neuron Culture and p75NTR shRNAs
Sympathetic neurons from P4 rat SCGs were cultured and transfected with
control or p75NTR shRNAs alone or cotransfected with wild-type or mutant
p75NTR as previously described (Kenchappa et al., 2006; Palmada et al.,
2002). The target sequence of the first p75NTR shRNA was ACGGACCTATCT
GAGCTGAAA, the second was ATGGCGTGACTTTCAGGGAAA. Control
shRNA was targeted against EGFP sequences. Three days after transfection,
neurons were treated with 200 ng/ml of BDNF for 1 hr and lysed in NP-40 buffer
(10% glycerol, 50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% NP-40, 1 mM
Na3VO4, 1 mM phenylmethylsulfonyl fluoride [PMSF], 2 mg/ml leupeptin
and aprotinin) to assess JNK activation. For cell survival assay, the cells
were fixed in 4% paraformaldehyde 48 hr after BDNF treatment and scored
for apoptosis as previously described (Kenchappa et al., 2006).
Biotinylation, Immunoprecipitation, Immunoblotting,
and Chemical Crosslinking
Cell surface proteins were biotinylated with Sulfo-NHS-LC-Biotin (Pierce).
Cells were lysed in buffer containing 1% Triton X-100, 60 mM octyl-glucosyde,
10 mM iodoacetamide, and protease inhibitors (Roche). For reducing condi-
tions, immunoprecipitates were boiled in sample buffer containing 1 M DTT.
Gels were blotted to PVDF membranes (Amersham). Biotinylated proteins
were detected using Neutravidin conjugated to alkaline phosphatase (Sigma).
Filters were developed by chemifluoresence (Amersham) and scanned on
a STORM840 fluorimager (MolDynamics). Radioiodination of NGF was done
with lactoperoxidase (Sigma), and EDAC/SulfoNHS (Pierce) was used as
chemical crosslinker. Autoradiography was done on a STORM840 phosphor-
imager. Quantifications of immunoblots and autoradiograms were done with
ImageQuant software (MolDynamics).
Assays of NF-kB, RhoA, and Cell Death
NF-kB activity was assayed using a luciferase reporter kit (Promega). NGF was
added 2 days after transfection and left for 24 hr prior to cell lysis. RhoA activity
was evaluated using a kit from Cytoskeleton. Cell death was assessed by the
TUNEL method using kits from Roche and Biocolor. NGF was added 2 days
after transfection and left for another day in serum free-medium prior to assay
of cell death.
ToxCAT Assay of Self-Association of Transmembrane Domains
The reporter system exploits the ability of the ToxR transcription activator of
the Vibrio Cholerae pathogen to bind the cholera toxin (ctx) gene promoter
only when dimerized. A transmembrane segment of interest fused to ToxR isNeuron 62, 72–83, April 16, 2009 ª2009 Elsevier Inc. 81
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(MBP). Varying amounts of ToxR dimers will be formed in the cytosol in direct
proportion to the oligomerization ability of the TM domain. Binding of dimer-
ized ToxR to the ctx DNA element triggers expression of a chloramphenicol
transferase (cat) gene reporter and production of CAT protein, which can
then be quantified by a CAT-ELISA kit (Roche Diagnostics) as described by
McClain et al. (McClain et al., 2003). Expression levels of different ToxR-TM-
MBP chimeras were determined by western blotting. The ToxR and ToxCAT
systems have been previously applied to demonstrate self-association of
a range of TM domains from glycophorin A (GpA) (Kubatzky et al., 2001), integ-
rin aIIb (Li et al., 2004), ErbB1 to -4 (Mendrola et al., 2002), and the Epo receptor
(Kubatzky et al., 2001).
Anisotropy Microscopy and FRET
Anisotropy microscopy was done as described by Squire et al. (Squire et al.,
2004) in transiently transfected COS-7 cells. Images were acquired 15–24 hr
posttransfection, using a Olympus IX81 inverted microscope (Olympus,
Germany) equipped with a MT20 illumination system. A linear dichroic polar-
izer (Meadowlark Optics, Frederick, Colorado, US) was placed in the illumina-
tion path of the microscope, and two identical polarizers were placed in an
external filter wheel at orientations parallel and perpendicular to the polariza-
tion of the excitation light. The fluorescence was collected via a 203 0.7 NA
air objective, and parallel and polarized emission images were acquired
sequentially on an Orca CCD camera (Hamamatsu Photonics, Japan). Data
acquisition was controlled by the CellR software supplied by the microscope
manufacturer. NGF (or vehicle) was added 1 min after the start of the time lapse
at a concentration of 100 ng/ml. Anisotropy values were extracted from image
stacks of 30 images acquired in both parallel and perpendicular emission
modes every 30 s for a time period of 15 min after NGF addition. For each
construct, two areas per field of view were measured in four independent
transfections performed in duplicate or triplicate. Fluorescence intensity and
anisotropy images were calculated as described by Squire et al. (Squire
et al., 2004). Wild-type and C257A p75NTR constructs were tagged at the
C terminus with a monomeric version of EGFP (Clontech) carrying the
A207K mutation that disrupts EGFP dimerization. A cytosolic EGFP monomer
(EGFP1) gave a mean anisotropy value of 0.295 ± 0.005 (no FRET), and
a concatenated EGFP trimer (EGFP3) gave a value of 0.2369 ± 0.013 (maximal
FRET), so thresholds for image analysis (done with Image J software) were set
between 0.2 and 0.35 (Figures 7A–7D).
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